The current price of MEDX.SW is CHF 11.06 — it has increased by 0.91% since the previous close. Data as of Nov 4, 2026.
MEDX.SW is up 5.94% over the past week, up 11.83% over the past month and up 26.40% over the past year. The price is above its 200-day moving average of CHF 9.27.
Of the 3 analysts covering medmix AG, 3 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
medmix AG has a market capitalization of CHF 450.21M. The company belongs to the Industrials sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, medmix AG posted earnings of CHF 0.0123 per share against an estimate of CHF 0.35, missing expectations by 96.49%. Upcoming reports are listed in the earnings calendar.
medmix AG reported revenue of CHF 216.15M in its most recent quarter, which has decreased by 4.10% compared with the same quarter a year earlier. Analysts had expected CHF 231M.
Yes. medmix AG pays dividends annually. The latest payment of CHF 0.10 per share has a payment date of Apr 22, 2026, which corresponds to a dividend yield of 1.12%.
In the latest trading session MEDX.SW moved between CHF 10.94 and CHF 11.16, a range of 1.99% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of medmix AG shows a strong buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for medmix AG is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks MEDX.SW has traded between CHF 7.61 and CHF 12.36. The current price is 10.52% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.